Clinical Associations of Anti‐ RNPC3 Autoantibodies in Mixed Connective Tissue Disease
ACR Open Rheumatology · 2026-04 · 8 (4)
DOI: 10.1002/acr2.90035 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACR Open Rheumatology, online erschienen am 07.04.2026. Verfasst von Darya S Jalaledin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fonds de la recherche du Québec en Santé Clinical Research Scholar Junior 1 Awards, Scleroderma Association of British Columbia, Scleroderma Manitoba.
Abstract (Originalsprache)
Objective
The RNA‐binding region‐containing protein 3 (RNPC3) protein acts as a molecular bridge, promoting U11/U12 RNP complex formation. In previous reports, patients with systemic sclerosis (SSc) with anti‐RNPC3 autoantibodies had an increased risk of interstitial lung disease (ILD), severe gastrointestinal (GI) disease, and cancer. The aim of this study was to compare phenotypic features of patients with mixed connective tissue disease (MCTD) with and without anti‐RNPC3 autoantibodies.
Methods
A retrospective MCTD cohort was studied. Addressable laser bead immunoassay was used to detect anti‐RNPC3 autoantibodies with
Autor:innen und Institutionen
- Division of Rheumatology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
- Division of Rheumatology, Hôpital de la Cité-de-la-Santé, Laval, Québec, Canada.
- Clinique Multidisciplinaire de Neuville, Neuville, Québec, Canada.
- Division of Internal Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
- Autoimmunity Research Laboratory, Centre Hospitalier de l'Université de Montréal Research Center, Montréal, Québec, Canada.
- Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
ORCID-Profile: Darya S Jalaledin, Sabrina Hoa, Martial Koenig, May Y Choi, Minoru Satoh, Marvin J Fritzler, Jean-Luc Senécal, Océane Landon-Cardinal
Förderung
- Fonds de la recherche du Québec en Santé Clinical Research Scholar Junior 1 Awards
- Scleroderma Association of British Columbia
- Scleroderma Manitoba
- Scleroderma Association of Saskatchewan
- Scleroderma Society of Canada
- Scleroderma Society of Ontario
- Sclérodermie Québec
- Myositis Canada
Zitieren
APA
Jalaledin, D. S., El Kamouni, H., Albert, A., Hoa, S., Bourré-Tessier, J., Rich, E., Goulet, J. R., Koenig, M., Pérez, G., Choi, M. Y., Troyanov, Y., Satoh, M., Fritzler, M. J., Senécal, J. L., & Landon-Cardinal, O. (2026). Clinical Associations of Anti‐ RNPC3 Autoantibodies in Mixed Connective Tissue Disease. ACR Open Rheumatology, 8(4). https://doi.org/10.1002/acr2.90035
Vancouver
Jalaledin DS, El Kamouni H, Albert A, Hoa S, Bourré-Tessier J, Rich E, et al. Clinical Associations of Anti‐ RNPC3 Autoantibodies in Mixed Connective Tissue Disease. ACR Open Rheumatology. 2026;8(4). doi:10.1002/acr2.90035
BibTeX
@article{Jalaledin2026,
author = {Jalaledin, Darya S and El Kamouni, Hajar and Albert, Alexandra and Hoa, Sabrina and Bourré-Tessier, Josiane and Rich, Eric and Goulet, Jean-Richard and Koenig, Martial and Pérez, Gemma and Choi, May Y and Troyanov, Yves and Satoh, Minoru and Fritzler, Marvin J and Senécal, Jean-Luc and Landon-Cardinal, Océane},
title = {Clinical Associations of Anti‐ RNPC3 Autoantibodies in Mixed Connective Tissue Disease},
journal = {ACR Open Rheumatology},
year = {2026},
volume = {8},
number = {4},
doi = {10.1002/acr2.90035}
}
EUVIMED